Multi-centre trial evaluating efti in combination with pembrolizumab and chemotherapy in patients with non-small cell lung ...
An announcement from Immutep Ltd ( (AU:IMM) ) is now available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback